data_1bds_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bds _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.418 -0.586 . . . . 1.97 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLY . . . -60.57 162.07 12.58 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.596 -0.842 . . . . 1.3100000000000001 110.821 -149.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -78.66 20.7 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 O-C-N 122.512 0.743 . . . . 0.88 111.294 166.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.82 126.4 31.28 Favored 'General case' 0 N--CA 1.512 2.662 0 C-N-CA 118.849 -1.141 . . . . 0.78000000000000003 108.369 -154.721 128.787 -155.697 115.57 106.441 2.017 102.08 164.306 -41.591 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.63 163.64 26.04 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.335 -1.346 . . . . 1.1899999999999999 110.241 -171.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.82 -177.8 3.24 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.923 -0.711 . . . . 1.04 109.547 174.944 -102.505 -39.149 -99.863 105.579 2.026 105.64 -91.331 64.942 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 7' ' ' SER . 50.9 p -91.19 110.61 21.89 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.981 -1.087 . . . . 1.9299999999999999 110.166 -166.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -29.38 12.64 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.637 -1.268 . . . . 1.3999999999999999 110.631 -166.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -108.26 114.81 59.09 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 119.088 -1.045 . . . . 1.73 110.191 -171.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.48 -161.55 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.934 1.089 . . . . 1.1200000000000001 110.396 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.68 -102.81 1.68 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.108 -1.52 . . . . 1.45 110.06 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -160.22 165.43 31.5 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.137 -1.025 . . . . 2.9900000000000002 111.485 -171.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.75 177.82 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.785 -1.198 . . . . 0.95999999999999996 110.319 152.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.75 124.05 27.8 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.807 -0.757 . . . . 1.28 109.621 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.447 ' H ' ' H ' ' A' ' 2' ' ' ALA . 17.5 tp -79.07 111.54 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.447 -1.701 . . . . 1.4399999999999999 110.078 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.487 ' N ' ' O ' ' A' ' 38' ' ' ILE . 67.3 m95 -93.44 157.89 15.99 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.687 -2.051 . . . . 0.46999999999999997 110.463 166.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.545 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -94.78 -153.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.431 -0.908 . . . . 2.6099999999999999 109.095 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.46 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.72 78.73 0.19 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 123.671 1.7 . . . . 2.2999999999999998 108.079 -169.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.8 mtp85 -121.33 133.63 55.12 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 111.553 -2.567 . . . . 2.5 110.036 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.43 -21.13 73.45 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.219 -1.467 . . . . 1.0800000000000001 110.377 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.39 155.17 45.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.447 -0.901 . . . . 1.24 110.572 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.18 154.57 54.72 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 119.411 -0.916 . . . . 0.51000000000000001 109.3 179.78 -124.741 161.617 -162.477 104.433 2.023 104.499 151.122 -154.14 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.91 141.38 93.35 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.034 1.156 . . . . 0.83999999999999997 111.127 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.77 -10.55 75.82 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.358 -1.401 . . . . 1.5900000000000001 110.385 -174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 -5.54 62.85 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.418 -1.372 . . . . 1.76 110.394 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -54.48 5.26 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.387 -0.925 . . . . 2.6800000000000002 110.351 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.59 1.1 1.7 Allowed Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.808 -1.186 . . . . 1.1899999999999999 110.677 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' CD2' ' SG ' ' A' ' 40' ' ' CYS . 40.2 m-85 -65.17 171.85 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.678 1.228 . . . . 0.92000000000000004 111.612 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 1.2 p -160.53 -38.2 0.05 OUTLIER 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 112.39 -2.186 . . . . 1.1100000000000001 107.263 165.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 41' ' ' TYR . 4.1 p -95.12 127.05 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.502 -1.681 . . . . 0.95999999999999996 109.404 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -150.4 158.8 44.55 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.283 -1.367 . . . . 1.8 111.883 176.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -125.0 147.85 48.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.459 -0.896 . . . . 0.91000000000000003 111.447 171.794 64.942 -91.331 -99.863 105.64 2.026 105.579 -39.149 -102.505 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 47.2 m-85 -126.86 128.26 46.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.732 -1.576 . . . . 1.0 110.024 -151.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -142.54 69.49 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.428 -0.909 . . . . 1.76 110.096 -167.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.431 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.87 157.24 2.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.149 -1.02 . . . . 2.3999999999999999 109.156 -171.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' C ' HD21 ' A' ' 37' ' ' ASN . 10.0 Cg_endo -78.66 39.1 0.5 Allowed 'Cis proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.656 -0.977 . . . . 1.01 110.934 -7.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.3 m-80 -140.29 -163.13 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.306 -0.958 . . . . 1.03 110.923 171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -159.61 151.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.895 -1.048 . . . . 1.0700000000000001 108.525 171.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.7 m -117.89 152.65 34.99 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 117.202 -1.799 . . . . 0.66000000000000003 111.155 152.366 -41.591 164.306 115.57 102.08 2.017 106.441 -155.697 128.787 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.5 t -126.17 142.4 51.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.288 -0.869 . . . . 0.34999999999999998 111.301 -157.645 -154.14 151.122 -162.477 104.499 2.023 104.433 161.617 -124.741 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.4 m-85 -117.73 166.42 13.46 Favored Pre-proline 0 N--CA 1.504 2.253 0 N-CA-C 108.867 -0.79 . . . . 1.1399999999999999 108.867 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.84 160.88 92.28 Favored 'Cis proline' 0 CA--C 1.504 -0.992 0 C-N-CA 124.613 -0.994 . . . . 1.7 112.843 6.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.575 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -3.004 0 CA-C-N 112.503 -2.135 . . . . 1.3600000000000001 110.173 164.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.418 -0.586 . . . . 1.47 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.556 ' H ' ' H ' ' A' ' 15' ' ' LEU . . . -60.57 162.07 12.58 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.596 -0.842 . . . . 0.77000000000000002 110.821 -149.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -78.66 20.7 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 O-C-N 122.512 0.743 . . . . 0.72999999999999998 111.294 166.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.82 126.4 31.28 Favored 'General case' 0 N--CA 1.512 2.662 0 C-N-CA 118.849 -1.141 . . . . 0.78000000000000003 108.369 -154.721 128.787 -155.697 115.57 106.441 2.017 102.08 164.306 -41.591 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.63 163.64 26.04 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.335 -1.346 . . . . 0.93000000000000005 110.241 -171.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.82 -177.8 3.24 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.923 -0.711 . . . . 1.04 109.547 174.944 -102.505 -39.149 -99.863 105.579 2.026 105.64 -91.331 64.942 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 7' ' ' SER . 50.9 p -91.19 110.61 21.89 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.981 -1.087 . . . . 1.5 110.166 -166.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -29.38 12.64 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.637 -1.268 . . . . 0.90000000000000002 110.631 -166.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -108.26 114.81 59.09 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 119.088 -1.045 . . . . 1.1000000000000001 110.191 -171.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.48 -161.55 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.934 1.089 . . . . 0.95999999999999996 110.396 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.68 -102.81 1.68 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.108 -1.52 . . . . 0.81999999999999995 110.06 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -160.22 165.43 31.5 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.137 -1.025 . . . . 2.48 111.485 -171.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.75 177.82 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.785 -1.198 . . . . 0.37 110.319 152.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.75 124.05 27.8 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.807 -0.757 . . . . 1.28 109.621 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.556 ' H ' ' H ' ' A' ' 2' ' ' ALA . 17.5 tp -79.07 111.54 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.447 -1.701 . . . . 0.87 110.078 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.724 ' CB ' HG23 ' A' ' 38' ' ' ILE . 67.3 m95 -93.44 157.89 15.99 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.687 -2.051 . . . . 0.41999999999999998 110.463 166.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.545 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -94.78 -153.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.431 -0.908 . . . . 2.1600000000000001 109.095 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.645 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.72 78.73 0.19 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 123.671 1.7 . . . . 1.6499999999999999 108.079 -169.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.8 mtp85 -121.33 133.63 55.12 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 111.553 -2.567 . . . . 1.9099999999999999 110.036 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.43 -21.13 73.45 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.219 -1.467 . . . . 0.62 110.377 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.39 155.17 45.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.447 -0.901 . . . . 0.63 110.572 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.18 154.57 54.72 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 119.411 -0.916 . . . . 0.51000000000000001 109.3 179.78 -124.741 161.617 -162.477 104.433 2.023 104.499 151.122 -154.14 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.91 141.38 93.35 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.034 1.156 . . . . 0.83999999999999997 111.127 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.77 -10.55 75.82 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.358 -1.401 . . . . 1.45 110.385 -174.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 -5.54 62.85 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.418 -1.372 . . . . 1.28 110.394 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -54.48 5.26 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.387 -0.925 . . . . 2.4900000000000002 110.351 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.59 1.1 1.7 Allowed Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.808 -1.186 . . . . 0.75 110.677 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.66 ' O ' HG23 ' A' ' 29' ' ' THR . 40.2 m-85 -65.17 171.85 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.678 1.228 . . . . 0.48999999999999999 111.612 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -160.53 -38.2 0.05 OUTLIER 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 112.39 -2.186 . . . . 0.51000000000000001 107.263 165.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 41' ' ' TYR . 4.1 p -95.12 127.05 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.502 -1.681 . . . . 0.56999999999999995 109.404 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -150.4 158.8 44.55 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.283 -1.367 . . . . 1.1200000000000001 111.883 176.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -125.0 147.85 48.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.459 -0.896 . . . . 0.81999999999999995 111.447 171.794 64.942 -91.331 -99.863 105.64 2.026 105.579 -39.149 -102.505 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD12 ' A' ' 38' ' ' ILE . 47.2 m-85 -126.86 128.26 46.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.732 -1.576 . . . . 0.62 110.024 -151.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -142.54 69.49 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.428 -0.909 . . . . 1.04 110.096 -167.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.87 157.24 2.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.149 -1.02 . . . . 1.79 109.156 -171.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.0 Cg_endo -78.66 39.1 0.5 Allowed 'Cis proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.656 -0.977 . . . . 1.0 110.934 -7.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 5.4 m120 -140.29 -163.13 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.306 -0.958 . . . . 0.58999999999999997 110.923 171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -159.61 151.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.895 -1.048 . . . . 0.28999999999999998 108.525 171.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.7 m -117.89 152.65 34.99 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 117.202 -1.799 . . . . 0.40999999999999998 111.155 152.366 -41.591 164.306 115.57 102.08 2.017 106.441 -155.697 128.787 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.5 t -126.17 142.4 51.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.288 -0.869 . . . . 0.29999999999999999 111.301 -157.645 -154.14 151.122 -162.477 104.499 2.023 104.433 161.617 -124.741 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.4 m-85 -117.73 166.42 13.46 Favored Pre-proline 0 N--CA 1.504 2.253 0 N-CA-C 108.867 -0.79 . . . . 0.57999999999999996 108.867 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.84 160.88 92.28 Favored 'Cis proline' 0 CA--C 1.504 -0.992 0 C-N-CA 124.613 -0.994 . . . . 1.7 112.843 6.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.575 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -3.004 0 CA-C-N 112.503 -2.135 . . . . 1.1399999999999999 110.173 164.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.418 -0.586 . . . . 1.47 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.556 ' H ' ' H ' ' A' ' 15' ' ' LEU . . . -60.57 162.07 12.58 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.596 -0.842 . . . . 0.77 110.821 -149.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -78.66 20.7 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 O-C-N 122.512 0.743 . . . . 0.73 111.294 166.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -80.82 126.4 31.28 Favored 'General case' 0 N--CA 1.512 2.662 0 C-N-CA 118.849 -1.141 . . . . 0.78 108.369 -154.721 128.787 -155.697 115.57 106.441 2.017 102.08 164.306 -41.591 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.63 163.64 26.04 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.335 -1.346 . . . . 0.93 110.241 -171.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.82 -177.8 3.24 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.923 -0.711 . . . . 1.04 109.547 174.944 -102.505 -39.149 -99.863 105.579 2.026 105.64 -91.331 64.942 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 7' ' ' SER . 50.9 p -91.19 110.61 21.89 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.981 -1.087 . . . . 1.5 110.166 -166.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -29.38 12.64 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.637 -1.268 . . . . 0.9 110.631 -166.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -108.26 114.81 59.09 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 119.088 -1.045 . . . . 1.1 110.191 -171.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.48 -161.55 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.934 1.089 . . . . 0.96 110.396 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.68 -102.81 1.68 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.108 -1.52 . . . . 0.82 110.06 168.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 5.5 ptm180 -160.22 165.43 31.5 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.137 -1.025 . . . . 2.48 111.485 -171.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -145.75 177.82 23.89 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.785 -1.198 . . . . 0.37 110.319 152.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' CYS . 1.1 m-20 -78.75 124.05 27.8 Favored 'General case' 0 C--O 1.184 -2.391 0 C-N-CA 119.807 -0.757 . . . . 1.28 109.621 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.556 ' H ' ' H ' ' A' ' 2' ' ' ALA . 17.5 tp -79.07 111.54 15.38 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 117.447 -1.701 . . . . 0.87 110.078 170.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.724 ' CB ' HG23 ' A' ' 38' ' ' ILE . 67.3 m95 -93.44 157.89 15.99 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.687 -2.051 . . . . 0.42 110.463 166.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.545 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -94.78 -153.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.431 -0.908 . . . . 2.16 109.095 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.645 HD12 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.72 78.73 0.19 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 123.671 1.7 . . . . 1.65 108.079 -169.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 17' ' ' ILE . 6.8 mtp85 -121.33 133.63 55.12 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 111.553 -2.567 . . . . 1.91 110.036 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.43 -21.13 73.45 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.219 -1.467 . . . . 0.62 110.377 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.39 155.17 45.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.447 -0.901 . . . . 0.63 110.572 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -87.18 154.57 54.72 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 119.411 -0.916 . . . . 0.51 109.3 179.78 -124.741 161.617 -162.477 104.433 2.023 104.499 151.122 -154.14 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.91 141.38 93.35 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.034 1.156 . . . . 0.84 111.127 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.77 -10.55 75.82 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.358 -1.401 . . . . 1.45 110.385 -174.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 -5.54 62.85 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 119.418 -1.372 . . . . 1.28 110.394 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -54.48 5.26 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.387 -0.925 . . . . 2.49 110.351 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.59 1.1 1.7 Allowed Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.808 -1.186 . . . . 0.75 110.677 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.66 ' O ' HG23 ' A' ' 29' ' ' THR . 40.2 m-85 -65.17 171.85 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.678 1.228 . . . . 0.49 111.612 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 28' ' ' TYR . 1.2 p -160.53 -38.2 0.05 OUTLIER 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 112.39 -2.186 . . . . 0.51 107.263 165.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 41' ' ' TYR . 4.1 p -95.12 127.05 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 113.502 -1.681 . . . . 0.57 109.404 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -150.4 158.8 44.55 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.283 -1.367 . . . . 1.12 111.883 176.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -125.0 147.85 48.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.459 -0.896 . . . . 0.82 111.447 171.794 64.942 -91.331 -99.863 105.64 2.026 105.579 -39.149 -102.505 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD12 ' A' ' 38' ' ' ILE . 47.2 m-85 -126.86 128.26 46.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.732 -1.576 . . . . 0.62 110.024 -151.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -142.54 69.49 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.428 -0.909 . . . . 1.04 110.096 -167.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HA ' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -51.87 157.24 2.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 119.149 -1.02 . . . . 1.79 109.156 -171.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 10.0 Cg_endo -78.66 39.1 0.5 Allowed 'Cis proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.656 -0.977 . . . . 1.0 110.934 -7.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' N ' ' HA ' ' A' ' 35' ' ' TRP . 1.3 m-80 -140.29 -163.13 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.306 -0.958 . . . . 0.59 110.923 171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -159.61 151.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.895 -1.048 . . . . 0.29 108.525 171.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 14' ' ' ASP . 4.7 m -117.89 152.65 34.99 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 117.202 -1.799 . . . . 0.41 111.155 152.366 -41.591 164.306 115.57 102.08 2.017 106.441 -155.697 128.787 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.61 ' SG ' ' CD2' ' A' ' 28' ' ' TYR . 3.5 t -126.17 142.4 51.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.288 -0.869 . . . . 0.3 111.301 -157.645 -154.14 151.122 -162.477 104.499 2.023 104.433 161.617 -124.741 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 30' ' ' SER . 1.4 m-85 -117.73 166.42 13.46 Favored Pre-proline 0 N--CA 1.504 2.253 0 N-CA-C 108.867 -0.79 . . . . 0.58 108.867 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.84 160.88 92.28 Favored 'Cis proline' 0 CA--C 1.504 -0.992 0 C-N-CA 124.613 -0.994 . . . . 1.7 112.843 6.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.575 ' C ' ' CD2' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.267 -3.004 0 CA-C-N 112.503 -2.135 . . . . 1.14 110.173 164.537 . . . . . . . . 2 2 . 1 stop_ save_